Icosagen

Icosagen is a private, independent family-business, advancing therapeutic proteins from mammalian cells since 26 years. As CRDMO, we uniquely combine pre-clinical CRO and clinical CDMO capabilities at one site, advancing molecules from discovery through R&D stages, into stable IcoCell(R) CHO cell lines and GMP manufacturing. From mAbs, complex multi-specifics to ADCs or recombinant proteins, we accelerate the programs of over 100 biotechs annually, eliminating error-prone tech transfers to save our partners' time, cost and effort.